|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.39 USD | -15.76% |
|
+17.80% | -65.93% |
| 07-09 | Aspira Women's Health Inc. announced that it has received $1.910249 million in funding | CI |
| 07-02 | Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday Ahead of Powell Speech | MT |
Aspira Women's Health Inc. announced that Minh Merchant will join the Company as General Counsel and Corporate Secretary, effective Jan. 4, 2022. In this role, Ms. Merchant will lead the Company's legal, compliance, and enterprise risk management functions, reporting to Valerie Palmieri, CEO.
Prior to joining Aspira, Ms. Merchant served as General Counsel, Corporate Secretary and Corporate Compliance Officer at Genome Medical Inc.
| 1st Jan change | Capi. | |
|---|---|---|
| -65.93% | 19.04M | |
| -33.27% | 9.11B | |
| +20.33% | 3.98B | |
| +9.96% | 2.5B | |
| -8.11% | 1.93B | |
| -26.17% | 1.86B | |
| +41.83% | 1.23B | |
| +52.50% | 955M | |
| -6.77% | 715M | |
| -18.99% | 237M |
ASPIRA WOMEN'S HEALTH INC. 
